Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • federete
    Junior Member
    • Feb 2013
    • 2

    #1

    RNA-seq and GC content bias

    Dear all,

    I am analyzing a dataset of RNA-seq (from Illumina Genome Analyser IIx), and have found some interesting expression pattern trends related to the GC content of genes. After reading the literature, I have noticed that RNA-seq has some biases related to the GC content. Hence, I am not sure of the validity of my inferences.

    So, my question, or questions are:
    -How can I determine if this is a biologically meaningful trend or rather so a bias of the methodology?
    -To what extent does the GC content biases the results of RNA-seq experiments? (the "trends" that I observe are strong)
    -I am working with published RPKM values, and was wondering if I need to recalculate all these values considering GC content biases or if I could just test how much bias is in the data.

    Any clue with any of these questions is highly appreciated!
    Federico
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Have a look at the conditional quantile normalization paper from Hansen et al. (http://biostatistics.oxfordjournals..../13/2/204.full). I expect that has much of what you're looking for.

    Comment

    • federete
      Junior Member
      • Feb 2013
      • 2

      #3
      Many thanks, dpryan

      I am not sure whether I could guess from the paper the extent of the influence of the GC content, but will do some tests with my data to see what can I see

      Fede

      Comment

      • amcloon
        Member
        • Sep 2012
        • 15

        #4
        This was also a concern of mine since I work with a GC-rich species, and it is clear from Aird et al, 2011 (Genome Biology 12:R18) that PCR conditions during library prep can non-uniformly amplify transcripts with different GC contents. If you are really seeing systematic biases, I would figure out what you did/had done during library construction (polymerase, buffers, etc.), to know if you can anticipate that you had biased amplification.

        I am not sure this will help your analysis any, but at least if your preparation didn't take this into account, you can write off some of the variability that way.

        Anna

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        15 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...